Caristo’s coronary inflammation technology identified cardiovascular risk missed by conventional [...]

A urinary biomarker profile improved five-year cancer risk prediction in [...]

iOnctura has reported immune-cell changes with roginolisib combinations in patients [...]

PsiThera has raised $25 million to advance oral TNFα and [...]

Mineralys Therapeutics has reported sustained blood pressure reductions with investigational [...]

Lonza has agreed to acquire five US contract development and [...]

iOnctura will present late-breaking clinical data on roginolisib in patients [...]

Newron Pharmaceuticals has completed enrolment of 618 patients in its [...]

Personalised cancer medicine is advancing, but better biomarker testing, clinical [...]

Formation Bio has launched a $600 million fund to acquire [...]